Holen Sie sich die Stockscreener-App
10.09
4.75%
-0.48
Schlusskurs vom Vortag:
$10.57
Offen:
$10.635
24-Stunden-Volumen:
552.33K
Relative Volume:
0.49
Marktkapitalisierung:
$981.21M
Einnahmen:
$1.85M
Nettoeinkommen (Verlust:
$-95.19M
KGV:
-4.5434
EPS:
-2.2208
Netto-Cashflow:
$-86.88M
1W Leistung:
+2.21%
1M Leistung:
+4.44%
6M Leistung:
+103.39%
1J Leistung:
+189.30%
1-Tages-Spanne:
$10.02
$10.69
1-Wochen-Bereich:
$9.40
$11.05
52-Wochen-Spanne:
$2.85
$11.05
Anteris Technologies Global Corp Stock (AVR) Company Profile
Firmenname
Anteris Technologies Global Corp
Sektor
Telefon
651-493-0606
Adresse
860 BLUE GENTIAN ROAD, EAGAN
Compare AVR vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVR
Anteris Technologies Global Corp
|
10.08 | 996.78M | 1.85M | -95.19M | -86.88M | -2.2208 |
ISRG
Intuitive Surgical Inc
|
426.49 | 150.88B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
157.46 | 43.56B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
42.81 | 36.52B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.22 | 33.97B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
219.34 | 30.41B | 5.54B | 1.52B | 1.74B | 10.37 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-12 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2026-03-11 | Eingeleitet | Wells Fargo | Overweight |
| 2025-01-08 | Eingeleitet | Lake Street | Buy |
| 2025-01-07 | Eingeleitet | Barclays | Overweight |
| 2025-01-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-01-07 | Eingeleitet | TD Cowen | Buy |
Alle ansehen
Anteris Technologies Global Corp Aktie (AVR) Neueste Nachrichten
ChartWatch ASX Scans: CSL, Cochlear, Artrya, Anteris Technologies, AMP, Zip Co, Graincorp, Pexa - Market Index
Anteris Technologies files form S-3 to register 5.39M shares via warrants - MSN
Could Anteris Technologies Global Corp (ASX:AVR) Continue Its Momentum After 162% One-Year Rally? - Kalkine
Anteris Technologies Reports Net CDI Reduction of 51,701 as Holders Shift to Nasdaq Common Stock in June 2026 - Kalkine
Anteris adjusts CDI and common stock balances amid ASX–Nasdaq transfers - TipRanks
Anteris Technologies Sees 51,701 Net CDI Decrease in June 2026 as Investors Shift Holdings to Nasdaq Shares - Kalkine Media
Anteris Files Shelf Registration to Support Advanced Heart Valve Portfolio - TipRanks
Anteris Technologies Files Offering of Up to 5.39 Million Shares - Moomoo
Anteris Technologies Reports Lapse of Restricted Stock Units and Options - TipRanks
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to Russell Microcap Value Benchmark Index - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to Russell 2000 Value Benchmark - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to Russell 3000 Value Benchmark - marketscreener.com
Price to earnings forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Price to earnings forward of Anteris Technologies Global Corp. – BOATS:AVR - TradingView
Enterprise value to EBITDA forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Anteris Technologies Global Corp. Actuals & Estimates (NASDAQ:AVR) - TradingView
AVR Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Price to sales forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Anteris Issues 45,631 New Shares from Conversion of Unquoted Securities - TipRanks
Anteris adds 23,072 new CDIs to ASX listing - TipRanks
Anteris Technologies Global Corp (AVR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Anteris Technologies Global Corp (AVR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to S&P Healthcare Equipment Select Industry Index - marketscreener.com
Anteris director David Roberts converts RSUs into common stock under long-term incentive plan - TipRanks
Anteris Technologies (AVR) Proxy filing Summary - Quartr
Anteris Technologies Global Corp (AVR) Institutional Confidence - TradingKey
Anteris Technologies Global Corp (AVR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Anteris Technologies Global Corp (AVR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Anteris Technologies Global Corp (AVR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Anteris Technologies Global Corp (AVR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Anteris Technologies Global Corp (AVR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Anteris Technologies Global Corp - TradingKey
Anteris Technologies (AVR) Surges 3.13% as Shares Approach Key Resistance at $10.04Moving Average Crossovers - dars.gov.et
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: Wider-than-Expected Losses as Development Pipeline ProgressesPretax Income Report - newsline.com
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: Wider-than-Expected Loss Reflects Continued Clinical InvestmentCore Business Growth - newsline.com
Funds from operations of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Anteris Technologies (AVR) director exercises 17,580 RSUs into common shares - Stock Titan
Anteris (AVR) CFO exercises options, delivers 39,595 shares for taxes - Stock Titan
AVR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: EPS Misses Estimates Significantly Amid Continued R&D InvestmentGAAP Earnings Report - newsline.com
Anteris Advances DurAVR Program Through ASX 300 Expansion - Kalkine Media
Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment; Shares Fall 6% - marketscreener.com
Update: Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment; Shares Fall 6% - Moomoo
Anteris Technologies Global Corp Gets French Regulatory Clearance For Duravr Paradigm Global Pivotal Trial - TradingView
Anteris Wins French Clearance to Expand Global DurAVR Heart Valve Trial - TipRanks
France clearance marks key milestone for Anteris' pivotal PARADIGM Trial - Yahoo Finance
Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment - marketscreener.com
Finanzdaten der Anteris Technologies Global Corp-Aktie (AVR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Anteris Technologies Global Corp-Aktie (AVR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Knight Susan Elizabeth | Director |
Jun 02 '26 |
Buy |
9.29 |
11,000 |
102,228 |
11,000 |
| L1 Capital Pty Ltd | 10% Owner |
Jan 22 '26 |
Buy |
5.75 |
5,000,000 |
28,750,000 |
13,219,814 |
2.23%
2.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):